Januskinase-Inhibitoren

Volume: 79, Issue: 3, Pages: 241 - 254
Published: Mar 26, 2020
Abstract
Background null Cytokines and associated intracellular signal cascades play a major role in the pathogenesis of autoimmune diseases. Janus kinases (JAK) are part of these intracellular signal transduction processes. A relatively new drug group of targeted synthetic disease-modifying antirheumatic drugs (tsDMARD) are JAK inhibitors (JAKi) and are a promising treatment approach for autoimmune diseases. null Efficacy null Hitherto, three JAKis,...
Paper Details
Title
Januskinase-Inhibitoren
Published Date
Mar 26, 2020
Journal
Volume
79
Issue
3
Pages
241 - 254
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.